Trial intelligence / Profile preview

Acute aspirin added to alteplase for ischemic stroke thrombolysis

NL-OMON31665Phase 3Not yet recruiting

Sponsor
Amsterdam University Medical Center
Start
Feb 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, open-label trial of aspirin and tissue-plasminogen activator in ischemic stroke, sponsored by Amsterdam University Medical Center. Planned start Feb 2008; status: not yet recruiting.

02

Drugs

aspirintissue-plasminogen activator
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NL-OMON31665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON31665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call